Express News | NYSE Order Imbalance 419856.0 Shares on Sell Side
ReutersMay 3 15:50 ET
Express News | NYSE Order Imbalance 237216.0 Shares on Buy Side
ReutersMay 2 15:50 ET
Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com
By Josh Nathan-Kazis Zoetis reported financial results for the first quarter that were slightly better than Wall Street expected as worries about its new pain medicines for dogs and cats continue to
Barron'sMay 2 09:06 ET
Express News | NYSE Order Imbalance 73554.0 Shares on Sell Side
ReutersMay 1 15:50 ET
Express News | NYSE Order Imbalance 213913.0 Shares on Buy Side
ReutersApr 30 15:50 ET
Express News | NYSE Order Imbalance 210292.0 Shares on Buy Side
ReutersApr 29 15:50 ET
The Spread of Avian Flu to Cattle Could Have Implications for Some Stocks
Seeking AlphaApr 26 07:16 ET
Express News | NYSE Order Imbalance 168202.0 Shares on Buy Side
ReutersApr 25 15:50 ET
Express News | NYSE Order Imbalance 818652.0 Shares on Buy Side
Moomoo 24/7Apr 24 15:50 ET
Express News | NYSE Order Imbalance 72994.0 Shares on Buy Side
Moomoo 24/7Apr 23 15:50 ET
Express News | NYSE Order Imbalance 263927.0 Shares on Buy Side
Moomoo 24/7Apr 22 15:50 ET
Express News | NYSE Order Imbalance 165981.0 Shares on Buy Side 165981.0 Shares on Buy Side
Moomoo 24/7Apr 19 15:50 ET
Express News | NYSE Order Imbalance 128261.0 Shares on Buy Side
Moomoo 24/7Apr 17 15:50 ET
Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement
PRNewswireApr 17 08:00 ET
United States Pet Medication Market Insights Report 2024-2029 Featuring Prominent Vendors - Boehringer Ingelheim, Ceva, Elanco Animal Health, Merck, Zoetis, Bayer AG, and Novartis - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "U.S. Pet Medication Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The U.S. Pet Medication Market was valued at USD 13.21
BusinesswireApr 17 07:11 ET
Unusual Options Activity: WBD, ULTA and Others Attract Market Bets, WBD V/OI Ratio Reaches 2181.8
EST Apr 16th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trend
moomoo NewsApr 16 16:30 ET
Express News | NYSE Order Imbalance 52032.0 Shares on Buy Side
Moomoo 24/7Apr 15 15:50 ET
Investors Aren't Buying Elanco Animal Health Incorporated's (NYSE:ELAN) Revenues
You may think that with a price-to-sales (or "P/S") ratio of 1.7x Elanco Animal Health Incorporated (NYSE:ELAN) is a stock worth checking out, seeing as almost half of all the Pharmaceuticals companie
Simply Wall StApr 10 09:08 ET
Express News | FDA Approved Pradalex (Pradofloxacin Injection) Solution For Certain Respiratory Diseases In Cattle And Swine; Approves New Antimicrobial Drug For Cattle And Swine; Pradalex Is Sponsored By Elanco U.S
Moomoo 24/7Apr 9 13:10 ET
S&P 500 Futures Flat In Premarket Trading; MicroStrategy, Marathon Digital Lead
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, MicroStrategy Inc. (MSTR) was up 11.5% in pre-marke
Dow JonesApr 8 07:31 ET
No Data
No Data